In the latest trading session,, 1.22 million Takeda Pharmaceutical Co ADR (NYSE:TAK) shares changed hands as the company’s beta touched 0.26. With the company’s most recent per share price at $14.75 changing hands around $0.2 or 1.41% at last look, the market valuation stands at $46.44B. TAK’s current price is a discount, trading about -5.29% off its 52-week high of $15.53. The share price had its 52-week low at $12.80, which suggests the last value was 13.22% up since then. When we look at Takeda Pharmaceutical Co ADR’s average trading volume, we note the 10-day average is 3.42 million shares, with the 3-month average coming to 2.31 million.
Analysts gave the Takeda Pharmaceutical Co ADR (TAK) stock a consensus recommendation rating of Buy, calculated at a mean rating of 2.00. If we narrow down to specifics, the data shows that 0 out of 3 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 1 recommended TAK as a Hold, 2 felt it is a Buy and 0 rated the stock as Underweight.
Takeda Pharmaceutical Co ADR (NYSE:TAK) trade information
Instantly TAK is in green as seen in intraday trades today. With action 0.24%, the performance over the past five days has been green. The company’s shares are showing year-to-date upside of 10.44%, with the 5-day performance at 0.24% in the green. However, in the 30-day time frame, Takeda Pharmaceutical Co ADR (NYSE:TAK) is 0.24% up. Looking at the short shares, we see there were 5.09 million shares sold at short interest cover period of 2.51 days.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 11.40%. The 2025 estimates are for Takeda Pharmaceutical Co ADR earnings to increase by 167.93%, but the outlook for the next 5-year period is at 47.17% per year.
TAK Dividends
Takeda Pharmaceutical Co ADR is expected to release its next quarterly earnings report on 2025-May-08. The 2.21% annual yield figure for the share gives it an annual dividend of 0.33. It is important to note, however, that the 2.21% dividend yield ratio should serve as a guide only, as you should also take into consideration many other aspects of a company’s operations and fundamentals before making any investment decision. During the past 5 years, the average dividend yield was 4.69 per year.
Takeda Pharmaceutical Co ADR (NYSE:TAK)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 0.01% of Takeda Pharmaceutical Co ADR shares while 2.28% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 2.28%. There are 2.28% institutions holding the Takeda Pharmaceutical Co ADR stock share, with CAPITAL RESEARCH GLOBAL INVESTORS the top institutional holder. As of 2024-06-30, the company held 0.8367% of the shares, roughly 13.13 million TAK shares worth $169.86 million.
MONDRIAN INVESTMENT PARTNERS LTD holds the second largest percentage of outstanding shares, with 0.4933% or 7.74 million shares worth $108.34 million as of 2024-06-30.
